Found: 31
Select item for more details and to access through your institution.
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Phase 1/2 study of CPX‐351 for patients with Int‐2 or high risk International Prognostic Scoring System myelodysplastic syndromes and chronic myelomonocytic leukaemia after failure to hypomethylating agents.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 3, p. 898, doi. 10.1111/bjh.19193
- By:
- Publication type:
- Article
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 4, p. 581, doi. 10.1111/bjh.19060
- By:
- Publication type:
- Article
Phase II study of azacitidine with pembrolizumab in patients with intermediate‐1 or higher‐risk myelodysplastic syndrome.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 378, doi. 10.1111/bjh.17689
- By:
- Publication type:
- Article
A phase 2 trial of mini‐hyper‐CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 11, p. 2229, doi. 10.1002/ajh.27463
- By:
- Publication type:
- Article
Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1780, doi. 10.1002/ajh.27070
- By:
- Publication type:
- Article
Performance of IPSS‐M in patients with myelodysplastic syndrome after hypomethylating agent failure.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. E281, doi. 10.1002/ajh.27043
- By:
- Publication type:
- Article
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. E91, doi. 10.1002/ajh.26858
- By:
- Publication type:
- Article
Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. 1560, doi. 10.1002/ajh.26724
- By:
- Publication type:
- Article
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T) and myelodysplastic syndrome with ring sideroblasts (MDS‐RS).
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. E246, doi. 10.1002/ajh.26182
- By:
- Publication type:
- Article
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46424-3
- By:
- Publication type:
- Article
Clonal Hematopoiesis: Malignant Implications, Extrahematologic Manifestations, and Management.
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, v. 22, n. 7, p. 320
- By:
- Publication type:
- Article
Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.7093
- By:
- Publication type:
- Article
Eosinophilia During Lenalidomide Therapy in Myelodysplastic Syndrome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 9, p. 629, doi. 10.1016/j.clml.2024.04.007
- By:
- Publication type:
- Article
MDS-439: A Simplified Three-Marker Panel for Myelodysplastic Syndrome Prognostic Outperforms the Well-Established Revised International Prognostic Scoring Systems (IPSS-R).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S351, doi. 10.1016/S2152-2650(21)01813-9
- By:
- Publication type:
- Article
Poster: MDS-439: A Simplified Three-Marker Panel for Myelodysplastic Syndrome Prognostic Outperforms the Well-Established Revised International Prognostic Scoring Systems (IPSS-R).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S229, doi. 10.1016/S2152-2650(21)01442-7
- By:
- Publication type:
- Article
LILRB4 Expression in CMML and MDS Based on Response to Hypomethylating Agents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S341, doi. 10.1016/j.clml.2019.07.343
- By:
- Publication type:
- Article
Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Concurrent Mutations in SF3B1 and PHF6 in Myeloid Neoplasms.
- Published in:
- Biology (2079-7737), 2023, v. 12, n. 1, p. 13, doi. 10.3390/biology12010013
- By:
- Publication type:
- Article
Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Natural history of newly diagnosed myelodysplastic syndrome with isolated inv(3)/t(3;3).
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. E326, doi. 10.1002/ajh.25991
- By:
- Publication type:
- Article
Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 11, p. 1399, doi. 10.1002/ajh.25950
- By:
- Publication type:
- Article
Invasive mucorales sinusitis in a young patient with Emberger syndrome and newly diagnosed AML: A case report and literature review of invasive fungal infections in GATA2 deficiency.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 529, doi. 10.1159/000525566
- By:
- Publication type:
- Article
Impact of frontline treatment approach on outcomes of myeloid blast phase CML.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01106-1
- By:
- Publication type:
- Article
NPM1‐mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentage.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 20, p. 3452, doi. 10.1002/cncr.35433
- By:
- Publication type:
- Article
A retrospective study of cladribine and low‐dose cytarabine–based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 560, doi. 10.1002/cncr.34564
- By:
- Publication type:
- Article
Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 19, p. 3552, doi. 10.1002/cncr.33745
- By:
- Publication type:
- Article
Aplastic anemia following the severe acute respiratory syndrome coronavirus‐2 vaccine.
- Published in:
- EJHaem, 2023, v. 4, n. 1, p. 288, doi. 10.1002/jha2.602
- By:
- Publication type:
- Article
Photo Quiz: To Scan or Not to Scan?
- Published in:
- Clinical Infectious Diseases, 2013, v. 56, n. 7, p. 1052, doi. 10.1093/cid/cis995
- By:
- Publication type:
- Article
It's Not That Simple.
- Published in:
- 2013
- By:
- Publication type:
- Letter